详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

Sustained release of hepatocyte growth factor by cationic self-assembling peptide/heparin hybrid hydrogel improves β-cell survival and function through modulating inflammatory response.

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Key Laboratory of Transplant Engineering and Immunology, West China Hospital. [2]Institute for Nanobiomedical Technology and Membrane Biology, Sichuan University, Chengdu, People's Republic of China.

出处：

DOI：

ISSN：

关键词： self-assembling peptide islet transplantation inflammation HGF slow release

摘要：

Inflammatory response is a major cause of grafts dysfunction in islet transplantation. Hepatocyte growth factor (HGF) had shown anti-inflammatory activity in multiple diseases. In this study, we aim to deliver HGF by self-assembling peptide/heparin (SAP/Hep) hybrid gel to protect β-cell from inflammatory injury. The morphological and slow release properties of SAPs were analyzed. Rat INS-1 β-cell line was treated with tumor necrosis factor α in vitro and transplanted into rat kidney capsule in vivo, and the viability, apoptosis, function, and inflammation of β-cells were evaluated. Cationic KLD1R and KLD2R self-assembled to nanofiber hydrogel, which showed higher binding affinity for Hep and HGF because of electrostatic interaction. Slow release of HGF from cationic SAP/Hep gel is a two-step mechanism involving binding affinity with Hep and molecular diffusion. In vitro and in vivo results showed that HGF-loaded KLD2R/Hep gel promoted β-cell survival and insulin secretion, and inhibited cell apoptosis, cytokine release, T-cell infiltration, and activation of NFκB/p38 MAPK pathways in β-cells. This study suggested that SAP/Hep gel is a promising carrier for local delivery of bioactive proteins in islet transplantation.

基金：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2016]版：

大类 | 1 区

工程技术

小类 | 2 区药学 3 区纳米科技

最新[2023]版：

大类 | 2 区

医学

小类 | 2 区药学 3 区纳米科技

第一作者：

第一作者机构： [1]Key Laboratory of Transplant Engineering and Immunology, West China Hospital.

通讯作者：

通讯机构： [1]Key Laboratory of Transplant Engineering and Immunology, West China Hospital. [*1]Key Laboratory of Transplant Engineering and Immunology, West China Hospital, No 1 Keyuan 4th Road, Gaopeng Avenue, Chengdu 610041, People’s Republic of China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Release of hydrophobic anticancer drug from a newly designed self-assembling peptide. [2]A self-assembling peptide RADA16-I integrated with spider fibroin uncrystalline motifs. [3]Self-assembling Peptide RADA16 Nanofibre Scaffold for a Cancer Cell Three-dimensional Culture [4]Self-assembling peptide RADA16 nanofibre scaffold for a cancer cell three-dimensional culture [5]Controlled release of paclitaxel from a self-assembling peptide hydrogel formed in situ and antitumor study in vitro. [6]CD44(+)/CD24(-) breast cancer cells exhibit phenotypic reversion in three-dimensional self-assembling peptide RADA16 nanofiber scaffold [7]A Miniature Cell Pattern Formation of Ovarian Cancer Cell Lines on Self-Assembling Peptide Nanofiber-Coated Coverslip and In Vitro Chemosensitivity Assay. [8]The effect of self-assembling peptide RADA16-I on the growth of human leukemia cells in vitro and in nude mice. [9]Influence of a self-assembling peptide, RADA16, compared with collagen I and Matrigel on the malignant phenotype of human breast-cancer cells in 3D cultures and in vivo. [10]Designer Self-Assembling Peptide Hydrogels to Engineer 3D Cell Microenvironments for Cell Constructs Formation and Precise Oncology Remodeling in Ovarian Cancer.